Cell And Gene Therapy Manufacturing Systems: Improved Therapies Through The Fusion Of Science And Industry

Bringing cell and gene therapies from laboratory development to commercial production requires manufacturing systems built around the product, process, and sensitivity of the cell material. Fraunhofer IPT and Harro Höfliger combine scientific expertise with production technology to support this transition. Their collaboration focuses on developing customized, fully automated solutions for manufacturing advanced therapy medicinal products, or ATMPs, to demanding quality standards. Careful product handling remains central throughout the process, helping manufacturers protect sensitive materials while improving efficiency and production readiness. By connecting early-stage development with scalable technology, the partnership addresses a critical challenge in advanced therapy manufacturing: translating scientific progress into reliable, market-ready production. Explore how tailored automation and production design can help promising therapies move beyond the laboratory.